CLINICAL_TRIALS
trial_result
· 2013-08-26
Clinical Trial Update: Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia [Phase 2]
Summary
A Phase 2 clinical trial evaluating azacitidine for chronic myelomonocytic leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Leeds | Conditions: Leukemia | Phase 2 | Status: COMPLETED